Pamela Aderhold

Pamela Aderhold has worked for a variety of organizations since 2015. Pamela began their career as a Medical Support Trainee at the University of Connecticut Student Health Services. In 2016, they worked as a Medical Scribe at the Baystate Medical Center. From 2018 to 2020, they held various roles at the Massachusetts General Hospital and Brigham and Women's Hospital, including Research Technician I and Research Trainee. In 2020, they became a Research Associate at Skyhawk Therapeutics, where they developed novel small molecules that modulated RNA splicing in autoimmune disease applications. Pamela is currently employed as a Research Scientist II and Research Scientist I at Werewolf Therapeutics.

Pamela Aderhold attended the University of Connecticut from 2014 to 2018, where they earned a Bachelor of Science in Diagnostic Genetic Sciences-- Molecular Diagnostics.